Rheumatology

Enrollment in DANFLU-2 trial was significantly more likely for those receiving single-page letter versus two-page letters

National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3 percent by 2033

Nonsignificant increase seen from 2023; 11.6 percent of adults aged 18 to 64 and 5.1 percent of children aged 0 to 17 were uninsured in 2024

Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications

Heaviest burden born by regions with high sociodemographic index, apart from Japan, which had declining trends

Patients with psoriatic arthritis are less likely to begin disease-modifying antirheumatic drug therapy